Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Extends Agilect User Fee Deadline Due To “Technical Error”

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA is extending the user fee deadline for Teva's Parkinson's disease agent Agilect (rasagiline) by three months following the firm's submission of additional data to clarify a "technical error.

You may also be interested in...



Eisai To Resubmit Aricept Severe Alzheimer’s sNDA In December

Firm is considering changing from paper to electronic filing to resolve formatting issues behind FDA’s refusal to file the sNDA.

Eisai To Resubmit Aricept Severe Alzheimer’s sNDA In December

Firm is considering changing from paper to electronic filing to resolve formatting issues behind FDA’s refusal to file the sNDA.

Avanir Neurodex NDA Delayed By FDA Request For Additional Analyses

Agency requested new summary analyses "to better support the new electronic data submission guidelines," the company says.

Related Content

Topics

UsernamePublicRestriction

Register

LL1135866

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel